Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Friday, 26 March 2021

Investorideas.com - Cannabis Stock News: Medcolcanna Organics (NEO: MCCN) is Granted Approximately 4% of Worlds Legal Production Quota of Medical Cannabis

Investorideas.com - Cannabis Stock News: Medcolcanna Organics (NEO: MCCN) is Granted Approximately 4% of Worlds Legal Production Quota of Medical Cannabis

New to Watch at Investor Ideas-New #Stocks in Biotech, Tech, Gaming (NYSE: $RBLX), Mining, & Cannabis (CSE: $GLOW.C)

  New to Watch at Investor Ideas-New #Stocks in Biotech, Tech, Gaming (NYSE: $RBLX), Mining, & Cannabis (CSE: $GLOW.C)

 


Point Roberts WA, Delta BC, March 26, 2021 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading retail investor and trader resource, announces its weekly roundup of stocks to watch in Biotech, Tech, Gaming, Mining, & Cannabis. Today’s stocks have been added to our lists of free stock directories in each sector.

 

Read this in full at https://www.investorideas.com/news/2021/main/03261Stocks.asp

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

 

New biotech & tech companies include February Nasdaq IPO’s, among other new listings. Tech companies are involved in cloud computing, Internet of Medical Things (IoMT) and specialty chemicals tech for other sectors within the technology industry.

 

The newest gaming company involves a digital community of creators, the latest mining company operates in Latin America and the newest cannabis company is focused on producing nutraceutical and cannabinoid-based products.

 

New Stocks added to Biotech Stocks Directory:

Sana Biotechnology, Inc. (NasdaqGS:SANA) is focused on creating and delivering engineered cells as medicines for patients. Sana shares a vision of repairing and controlling genes, replacing missing or damaged cells, and making its therapies broadly available to patients. Sana is more than 250 people working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, Cambridge, and South San Francisco.

 

Sensei Biotherapeutics, Inc. (NasdaqGS:SNSE) is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company has developed a proprietary bacteriophage-based platform, ImmunoPhage™, that enables the rapid generation of immune activating therapeutic agents that fully engage the immune system. Using the ImmunoPhage™ platform, Sensei is developing a library of ImmunoPhage, called Phortress™, to target multiple tumor-associated antigens to create a personalized yet off-the-shelf cocktail approach for treating cancer patients. The platform enables efficient, scalable and cost-effective manufacturing to support all of Sensei’s clinical programs. The company’s most advanced immunotherapy, SNS-301, a first-in-class ImmunoPhage™ targeting the tumor antigen Aspartyl beta Hydroxylase (ASPH), is currently in a Phase 1/2 clinical trial in patients with advanced Squamous Cell Carcinoma of the Head and Neck. Earlier stage programs include SNS-401, a ImmunoPhage™ cocktail for the treatment of Merkel Cell Carcinoma, and SNS-VISTA, an antibody-based therapeutic targeting an immune checkpoint gene that inhibits anti-tumor immune responses called V-domain Ig suppressor of T cell activation (VISTA).

 

Landos Biopharma, Inc. (NasdaqGM:LABP) is a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases that are the first to target new mechanisms of action, including the LANCL2, NLRX1 and PLXDC2 immunometabolic pathways. Landos Biopharma’s core expertise is in the development of therapeutic candidates targeting novel pathways at the interface of immunity and metabolism. Lead asset BT-11 is a novel, oral, gut-restricted small molecule therapeutic candidate for the treatment of ulcerative colitis and Crohn’s disease that targets the LANCL2 pathway. NX-13 is a novel, oral, gut-restricted compound for the treatment of inflammatory bowel disease, which targets the NLRX1 pathway. Additional candidates are in development for the treatment of lupus nephritis, rheumatoid arthritis, multiple sclerosis, and diabetes.

 

New Stocks added to Tech Stocks Directory:

Atotech Ltd (NYSE:ATC) is a leading specialty chemicals technology company and a market leader in advanced electroplating solutions. Atotech delivers chemistry, equipment, software, and services for innovative technology applications through an integrated systems-and-solutions approach. Atotech solutions are used in a wide variety of end-markets, including smartphones and other consumer electronics, communications infrastructure, and computing, as well as in numerous industrial and consumer applications such as automotive, heavy machinery, and household appliances. Atotech, headquartered in Berlin, Germany, is a team of 4,000 experts in over 40 countries generating annual revenues of $1.2 billion (2020). Atotech has manufacturing operations across Europe, the Americas, and Asia. With its well-established innovative strength and industry-leading global TechCenter network, Atotech delivers pioneering solutions combined with unparalleled on-site support for over 9,000 customers worldwide.

 

Xigem Technologies Corporation (CSE: XIGM) Established in Toronto, Ontario, the Company is positioned to become a leading Software as a Service (“SaaS”) technology platform for the emerging remote economy, with software capable of improving the capacity, productivity, and overall remote operations for businesses, consumers and other organizations. “iAgent,” the Company’s patented technology will provide organizations, businesses and consumers with the tools necessary to thrive in a vast array of remote working, learning and treatment environments.

 

Tevano Systems Holdings Inc. (CSE:TEVO) is a technology company with custom and proprietary hardware and software technologies, and cloud services utilized in digital kiosks in commercial settings. Tevano Systems is the developer of Health Shield™, an AI-driven, electronic tablet that video displays a user with their body temperature and notifies them if they need to wear a face mask. Health Shield™ devices would be placed at all entrances that patrons and/or employees would use to gain access to a building. This hardware is coupled with a cloud software solution used to manage multiple devices and provide detailed reports of all scans done throughout an enterprise.

 

ON24 INC. (NYSE:ONTF) provides a leading cloud-based Digital Experience Platform that makes it easy to create, scale, and personalize engaging experiences to drive measurable business growth. Today, we are helping over 1,900 companies worldwide, including 3 of the 5 largest global technology companies, 4 of the 5 largest US Banks, 3 of the 5 largest global healthcare companies, and 3 of the 5 largest global industrial manufacturing companies, convert millions of prospects to buyers. Through interactive webinars, virtual events, and always-on multimedia experiences, ON24 provides a system of engagement, powered by AI, which enables businesses to scale engagement, conversions, and pipeline to drive revenue growth. The ON24 platform supports an average of 4 million professionals a month totaling over 2.5 billion engagement minutes per year. ON24 is headquartered in San Francisco with global offices in North America, EMEA, and APAC

 

WellteQ Digital Health Inc. (CSE:WTEQ) is a leading provider of corporate wellness solutions developed to provide data-driven personalized health and wellness coaching to engage its users in healthier behaviours. As an enterprise (business-to-business) model WellteQ currently has two main sectors of customers, employers and insurance companies. WellteQ have secured a large multinational portfolio of customers, including UBS, DBS and Bupa Insurance, and reseller partners like Willis Towers Watson, Advanced Human Imaging and Garmin. WellteQ is developing its newly acquired Internet of Medical Things (IoMT) technologies for connected patient applications in healthcare which will extend the WellteQ’s continuum of care from preventative wellness through to virtual healthcare.

 

New Stock added to Gaming Stocks Directory:

Roblox Corp (NYSE:RBLX) mission is to build a human co-experience platform that enables shared experiences among billions of users. Every day, more than 32.6 million people around the world have fun with friends as they explore millions of immersive digital experiences. All of these experiences are built by the Roblox community, made up of over eight million creators. We believe in building a safe, civil, and diverse community—one that inspires and fosters creativity and positive relationships between people around the world.

 

New Stocks added to Mining Stocks Directory:

Cascada Silver Corp. (CSE: CSS) is focused on exploring for economically viable silver deposits in Latin America. Currently, Cascada has four properties under option in Chile, including the historical Agua Amarga Silver Property which was the focus of high grade silver mining during 19th century.   Cascada's professional management team has a history of making significant discoveries in Chile over the past 20 years including the Volcan and Cerro Maricunga deposits.

 

New Stocks added to Cannabis stocks Directory:

Glow LifeTech Corp. (CSE:GLOW) is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption and effectiveness. Glow LifeTech has rights to the groundbreaking, plant-based MyCell Technology® delivery system, which transforms poorly absorbed natural compounds into enhanced water-compatible concentrates, unlocking the full healing potential of natural active compounds.

 

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases, research and our own original financial content. We were one of the first retail investor sites to cover renewable energy and cleantech stocks at investorideas.com and our domain Renewableenergystocks.com. We were also one of the most well- known and cited defense stock sites, featuring our domain Homelanddefensestocks.com at its peak.

We follow the money for investors as sector sentiment shifts and technology disrupts. Our mission is to provide investor ideas with breaking news, resources, industry articles and interviews with leading experts.      

 

Learn about investing in stocks and sector trends with our news alerts, articles,  podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto CornerPlay by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate ChangeExploring Mining and the AI Eye.

 

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.  

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android  

 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Thursday, 25 March 2021

Investor Ideas #Potcasts 545, #Cannabis News and #Stocks on the Move; (OTCQB: $ALID) (OTC: $LRSV), (CSE: $RAMM.C) (OTC: $RAMMF), (TSX: $ZENA.TO)

 



 

Investor Ideas #Potcasts 545, #Cannabis News and #Stocks on the Move; (OTCQB: $ALID) (OTC: $LRSV), (CSE: $RAMM.C) (OTC: $RAMMF), (TSX: $ZENA.TO)

 

Delta, Kelowna, BC, March 25, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/032521-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/03251ALID-LRSV-RAMM-ZENA.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we look at a few public company announcements.

 

Allied Corp. (OTCQB: ALID) an international medical company focused on creating and providing health solutions to address today’s medical mental health issues announced that it has successfully filed for trademark protection for its pharmaceutical product “PSILONEX.

 

PSILONEX is a proprietary formulation prescribed within a treatment path that involves both

a pharmaceutical psilocybin-based formulation, followed by a daily cannabinoid maintenance period. PSILONEX is intended to be prescribed by a physician as “PSILONEX Rx,” followed by the cannabinoid daily therapy that can be purchased by the consumer in regions where it is legal to do so as “PSILONEX Daily,” Both of these products are currently being researched, developed and tested by Allied’s pharmaceutical development team.

 

The filed trademark protects Allied’s intellectual property for PSILONEX covering: chemical preparations for pharmaceutical or medical purposes, namely, for treating depression, anxiety, and PTSD, and for improving mental health; Nutraceuticals for the treatment of mental health disorders and conditions, including depression, anxiety, and PTSD; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for improving mental health; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for the treatment and prevention of mental health disorders; Pharmaceuticals, namely, psychotropics; Dietary and nutritional supplements; Fungal extracts sold as a component ingredient of nutritional supplements and vitamins; Providing a website featuring information in the field of mental health and physical health, including living a healthy and disease-free life; Providing a website featuring information about health, wellness and nutrition; and Providing a website featuring information concerning alternative health and healing.

 

Link Reservations Inc. (OTC: LRSV), a provider of wellness and cannabidiol (CBD) products for both humans and pets, announced that the company is preparing to launch its first functional mushroom product, DailyLife CBD Immune. The new tincture product, tailored for people, will feature both CBD and a wide spectrum of functional mushrooms (including Lion's Mane) which help boost the immune system.

 

"This is an exciting first step for the Company and we are thrilled to soon bring to market our first CBD mushroom product. Our focus has always been on providing high quality products that can help people benefit from the power of natural ingredients, and that is what we have aimed for with this product," commented Rene Lauritsen, Link Reservations Inc CEO. "Understandably, people are focusing on their health now more than ever and looking for ways in which they can boost their immunity, particularly in a natural way. Our goal is to fully satisfy their need with this new product. We have been researching the benefits of functional mushrooms for the past few months and have developed a product that will harness their power," added Lauritsen.

 

As the world continues to reel from the Coronavirus pandemic, and learns to live with the virus, many people are focusing on different ways to boost their immune system. According to Rick Miller, Associate Director of Food & Drink Specialised Nutrition at Mintel, the majority of consumers in Europe purchase vitamins, minerals and supplements that strengthen the immune system, while in the US, 35% of consumers think products that support the immune health would motivate them when making a purchase.

 

DailyLife CBD Immune will feature an organic blend of 13 different medicinal mushrooms, including Lion's Mane, Turkey Tail, Chaga, Red Reishi and Cordyceps, amongst others. By focusing on a variety of mushrooms the product is able to encompass multiple immune boosting traits and benefits. In addition, DailyLife CBD Immune also includes 250mg of hemp oil CBD extract and 100mg of vitamin C, which will add to the immune boosting benefits.

 

"We are confident that this product and our future ones will have a very warm reception in the market, and we look forward to sharing more developments as they arise through press releases," ended Lauritsen.

 

For more information about DailyLifeCBD please visit: https://dailylifecbd.com/.

 

DailyLifeCBD is sister brand to LinkResPet, a website focused on providing CBD pet products for dogs, cats and horses. For more information about LinkResPet, please visit www.linkrespet.com or follow them on Twitter on @res_pet

 

RAMM Pharma Corp. (CSE: RAMM) (OTC: RAMMF), a leader in plant-derived cannabinoid pharmaceutical products, announced that it has initiated clinical trials studying the efficacy of its proprietary NettaVet™ pet cannabinoid formulation for the treatment of four pathologies in animals. The trials will be conducted in partnership with Universidad de la Republica de Uruguay in collaboration with leading international experts at Montreal University (Canada), University of Buenos Aires (Argentina), São Paulo State University (Brazil) and University of Barcelona (Spain). NettaLife is a wholly owned subsidiary of RAMM, dedicated to the production, export and commercialization of pet products, food, pharmaceutical specialties and cosmetic products for animals. More information can be found on NettaLife’s website www.nettalife.com.

The clinical trials will evaluate the efficacy of NettaVet™ cannabinoid formulations for the treatment of the following pathologies:

      Chronic Osteoarthritis pain in dogs (Cannis familiaris)

      Chronic Osteoarthritis pain in horses (Equus caballus)

      Allergic Dermatitis in dogs (Cannis familiaris)

      Anxiety in dogs (Cannis familiaris)

Prof. Dr. Nadia Crosignani, MSc., PhD (UdelaR, Uruguay), lead advisor for the clinical trials stated, “We are, from an academic stand point, very excited to be able to conduct these clinical trials together with RAMM Pharma and the prospects for these novel treatments to improve the quality life of animals.”

“We are pleased to commence this initial set of clinical trials with renowned experts to advance the development of products to help address some of the most common animal ailments,” stated Jack Burnett, Chief Executive Officer.

The NettaVet™ team is developing a line of specialized CBD veterinary and medicinal products for animals. CBD has shown benefits in animals including pain and inflammation reduction, immune system improvement, skin and fur care and cognitive support. NettaVet™ products will offer a natural, holistic medical alternative for animal care and which we believe may produce therapeutic results for diagnosed conditions such as Idiopathic epilepsy, canine lymphoma and anxiety, without the negative side effects of traditional veterinary medications. CBD is renowned as a very well-tolerated medication and nutraceutical that doesn't produce harmful side effects. In addition, CBD-based products are believed not to damage the kidneys, liver or gastrointestinal system. This business line will synergistically leverage RAMM’s pharmaceutical expertise to continue to further the development of its products which will begin being rolled out in 2021.

 

Zenabis Global Inc. (TSX: ZENA) announced the launch of pre-roll multipacks as well as new distribution agreements.

 

Zenabis' continues to expand on the popularity of its value-oriented Re-Up portfolio with the launch of its new 10 and 20, Multi-Pack Indica and Sativa 0.5g Pre-Roll formats. This unique, multi-pack will be available initally in Quebec and Alberta in the larger, 20-pack format in early April with national rollout of both formats expected to be in time for the 4/20 celebrations. The full impact of the launch is expected to be reflected in Zenabis's Q2 2021 results.

 

Zenabis' multipack pre-roll offering will serve consumers seeking better value for money and larger package sizes to reduce the frequency of purchases. These new products build on the success of Zenabis popular 28g Re-Up Indica / Sativa products. The launch of the 10 / 20  Multi-Pack Pre-Roll format underpins Zenabis strategy of leveraging its ability to deliver the quality and affordability expected by its loyal customer base while delivering on the top and bottom line performance anticipated by shareholders.

 

Zenabis is also excited to announce that it has concluded agreements with Cannabis NL (Newfoundland and Labrador) and the government of Nunavut, completing its goal of extending the availability of its Namaste and Re-Up products to all Canadian provinces and territories. Shipments under these new agreements commence in April.  Zenabis joins a small, select group of Canadian LPs whose product quality and value have been recognized as a must-have, on-shelf product by every Provincial & Territorial Board in Canada. These new agreements further cement Zenabis as one of the top recreational LP's in the country. 

 

"Finalizing agreements with Cannabis NL and the government of Nunavut, which means making good on our promise of making our Namaste and Re-Up brands available from coast-to-coast-to-coast, is a benchmark moment for this organization. We continue to portray what a lean, nimble company that grows really, really good cannabis can achieve.  The addition of the pre-roll multipack to our assortment builds on Re-Up's brand purpose of providing affordable, high-THC products to our value-oriented customers" stated Robert Maxwell, Zenabis' Vice President, Sales and Marketing.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio ,  Google Play Music and most audio platforms available.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. LRSV is a frequent paid client for our news publishing  service

Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

#Psilocybin #Stocks in the News: Link Reservations Inc/LinkResPet (OTC: $LRSV) Preparing to Launch Immunity Boosting #Mushroom Product; @res_pet

 

#Psilocybin #Stocks in the News: Link Reservations Inc/LinkResPet (OTC: $LRSV) Preparing to Launch Immunity Boosting #Mushroom Product; @res_pet

 

London, UK  March 25, 2021– Breaking Health and Wellness functional mushroom stock news from Investorideas.com Newswire - Link Reservations Inc. (OTC: LRSV), a provider of wellness and cannabidiol (CBD) products for both humans and pets, announces the company is preparing to launch its first functional mushroom product, DailyLife CBD Immune. The new tincture product, tailored for people, will feature both CBD and a wide spectrum of functional mushrooms (including Lion's Mane) which help boost the immune system.

 

Read this news, featuring LRSV in full at https://www.investorideas.com/news/2021/lohas/03251LRSV-Immunity-Boosting-Mushroom.asp

 

"This is an exciting first step for the Company and we are thrilled to soon bring to market our first CBD mushroom product. Our focus has always been on providing high quality products that can help people benefit from the power of natural ingredients, and that is what we have aimed for with this product," commented Rene Lauritsen, Link Reservations Inc CEO. "Understandably, people are focusing on their health now more than ever and looking for ways in which they can boost their immunity, particularly in a natural way. Our goal is to fully satisfy their need with this new product. We have been researching the benefits of functional mushrooms for the past few months and have developed a product that will harness their power," added Lauritsen.

 

As the world continues to reel from the Coronavirus pandemic, and learns to live with the virus, many people are focusing on different ways to boost their immune system. According to Rick Miller, Associate Director of Food & Drink Specialised Nutrition at Mintel, the majority of consumers in Europe purchase vitamins, minerals and supplements that strengthen the immune system, while in the US, 35% of consumers think products that support the immune health would motivate them when making a purchase.

 

DailyLife CBD Immune will feature an organic blend of 13 different medicinal mushrooms, including Lion's Mane, Turkey Tail, Chaga, Red Reishi and Cordyceps, amongst others. By focusing on a variety of mushrooms the product is able to encompass multiple immune boosting traits and benefits. In addition, DailyLife CBD Immune also includes 250mg of hemp oil CBD extract and 100mg of vitamin C, which will add to the immune boosting benefits.

 

"We are confident that this product and our future ones will have a very warm reception in the market, and we look forward to sharing more developments as they arise through press releases," ended Lauritsen.

 

For more information about DailyLifeCBD please visit: https://dailylifecbd.com/

 

DailyLifeCBD is sister brand to LinkResPet, a website focused on providing CBD pet products for dogs, cats and horses. For more information about LinkResPet, please visit www.linkrespet.com or follow them on Twitter on @res_pet.

 

About Link Reservations Inc.

Link Reservations Inc is a CBD and wellness product provider dedicated to improving the health and life conditions of both people and pets worldwide. Its trades through its two brands; LinkResPet and DailyLifeCBD. LinkResPet develops and markets hemp-based CBD products for cats, dogs and horses. DailyLifeCBD provides everyday hemp-based CBD wellness products for people. The Company has operations in both the US and Europe.

 

Forward-Looking Statements & Disclaimers:

The information in this Press Release includes certain "forward-looking" statements within the meaning of the Safe Harbor provisions of Federal Securities Laws, as that term is defined in section 27a of the United States Securities Act of 1933, as amended, and section 21e of the United States Securities Exchange Act of 1934, as amended. Statements in this document, which are not purely historical, are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Investors are cautioned that such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including the future financial performance of the Company. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release, and the Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.

 

Link Reservations Inc:
400 Thames Valley Park Drive
Reading Berkshire RG6 1 PT
United Kingdom
Phone: +44 330 808 0897

 

Paid News -Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure : this news release featuring LRSV is a paid for news release on Investorideas.com  More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

About Investorideas.com

https://www.investorideas.com/About/

 

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others. 

 

 

Health, Wellness and Sustainability Stocks Research and News at Investorideas.com - investing ideas for a better world

Like Health, Wellness and Sustainability Stocks? View our LOHAS Stocks Directory

 

 

Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories

 

 

New Cannabis Stock: Humble & Fume Inc. (HMBL)

New Cannabis Stock: Humble & Fume Inc. (HMBL)